SARS-CoV-2 vaccination response in pediatric oncology patients.

Amber Marie D'SouzaMaria ThomasManu GnanamonyThu Hien NguyenPedro A de Alarcon

Published in: Pediatric blood & cancer (2023)

Pediatric oncology patients have a suboptimal immune response to SARS-CoV-2 vaccination. Booster doses will be imperative to provide optimal protection against COVID-19; however, blood counts may not be a useful guide to optimize the time of administration.

Keyphrases

sars cov
end stage renal disease
immune response
newly diagnosed
ejection fraction
chronic kidney disease
coronavirus disease
prognostic factors
patient reported outcomes
dendritic cells
patient reported
toll like receptor